Prognostic Factors and Impact of Treatment in Melanoma Brain Metastases: Better Prognosis for Women?

Publisher： Karger

E-ISSN： 1421-9832|215|1|10-16

ISSN： 1018-8665

Source： Dermatology, Vol.215, Iss.1, 2007-06, pp. : 10-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Tumor Volume as a Prognostic Factor in Resectable Malignant Melanoma

By  

Dermatology, Vol. 228, Iss. 1, 2013-12 ,pp. : 66-70

Karger

Access to resources Recommend Favorite

Current Guidelines in Melanoma Treatment

By  

Dermatology, Vol. 200, Iss. 2, 2000-04 ,pp. : 160-166

Karger

Access to resources Recommend Favorite

Topical Immunotherapy with Diphenylcyclopropenone in Combination with DTIC and Radiation for Cutaneous Metastases of Melanoma

By  

Dermatology, Vol. 211, Iss. 4, 2005-12 ,pp. : 370-371

Karger

Access to resources Recommend Favorite

Systemic Phototoxicity following Intralesional Rose Bengal for Subcutaneous Melanoma Metastases

By  

Dermatology, Vol. 216, Iss. 4, 2008-02 ,pp. : 361-362

Karger

Access to resources Recommend Favorite